RB Group was awarded Front End Study contract in May 2010 RBPC was awarded Design and Manage Contract in August 2010.
The Building was completed to IQ stage in April 2011 Pharmaceutical Formulated Product Facility to manufacture a Potent Schedule 2 controlled drug with an OEL of 700 nanograms/m3 Feasibility Study, Front End study, Detailed design, construction management, Validation, CDM Requirements
Mike Battrum, Head of Engineering commented: “RB Group delivered a class leading potent manufacturing facility to budget on time.”
You may download a pdf of this case study via the link below.
Our experienced engineering team could support you on your next project. Why not contact Genghis Perriman our Business Development Manager to discuss further for a no-obligation discussion?